Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 631–645 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5405 SCN4A Gene NGS Test for Paramyotonia Congenita (von Eulenburg) This test sequences the entire SCN4A gene to detect mutations associated with paramyotonia congenita.	EDTA whole blood, extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCN4A gene sequence", "Point mutations", "Small deletions/insertions", "Copy number variants"] Parameters [] Preparation ["No fasting required", "No medication stoppage required", "Mandatory pre-test genetic counselling"] Indications ["Suspected paramyotonia congenita", "Family history of myotonia", "Differential diagnosis of myotonic disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81314-2 ICD-10: G71.1 Clinical summary This test sequences the entire SCN4A gene to detect mutations associated with paramyotonia congenita.
TEST-4089 SCN5A Gene (Ventricular Fibrillation, Familial Paroxysmal Type 1) Genetic Test This test analyzes the SCN5A gene for variants associated with inherited cardiac arrhythmias and sudden cardiac death risk.	Whole Blood (EDTA) or DNA (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCN5A gene variants", "Pathogenic and likely pathogenic variants"] Parameters [] Preparation ["No fasting or special preparation is required."] Indications ["Evaluation of familial paroxysmal ventricular fibrillation type 1", "Risk stratification for sudden cardiac death", "Guidance for ICD placement", "Family cascade screening"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: I49.01 Clinical summary This test analyzes the SCN5A gene for variants associated with inherited cardiac arrhythmias and sudden cardiac death risk.
TEST-4464 SCN9A Gene Primary Erythromelalgia Genetic Test This test evaluates the SCN9A gene for mutations associated with primary erythromelalgia.	Whole blood, extracted DNA, or FTA card	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCN9A gene sequence", "Pathogenic variants (SNVs, indels)"] Parameters [] Preparation [] Indications ["Suspected inherited erythromelalgia", "Differential diagnosis of neuropathic pain", "Familial risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 94026-8 ICD-10: I73.81 Clinical summary This test evaluates the SCN9A gene for mutations associated with primary erythromelalgia.
TEST-4169 SCN9A Gene Sequencing (NGS) for Dravet Syndrome Modifier Variants Test This test identifies genetic variants in the SCN9A gene that may modify the clinical presentation and treatment response in individuals with Dravet syndrome.	Whole Blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 weeks (expedited available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCN9A gene variants (missense, nonsense, splice-site, copy-number variants)", "Phenotypic modifiers influencing Dravet syndrome severity"] Parameters [] Preparation ["No fasting required", "No medication discontinuation unless advised by physician"] Indications ["Prognostic assessment in SCN1A-positive Dravet syndrome", "Guidance for personalized treatment strategies", "Understanding phenotypic variability in Dravet syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 94762-2 ICD-10: G40.3 Clinical summary This test identifies genetic variants in the SCN9A gene that may modify the clinical presentation and treatment response in individuals with Dravet syndrome.
TEST-3521 SCNN1A Gene Pseudohypoaldosteronism Type 1 Autosomal Recessive Genetic Test This test identifies mutations in the SCNN1A gene associated with autosomal recessive pseudohypoaldosteronism type 1 (PHA1). It analyzes the entire gene sequence to detect variants...	Whole blood (EDTA tube) or dried blood spot (FTA card)	21–28 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCNN1A gene sequence", "Coding exons", "Splice sites"] Parameters [] Preparation ["Informed consent required", "Pre-test genetic counselling recommended"] Indications ["Infants and children presenting with salt-wasting symptoms", "Carrier screening in families with a known SCNN1A mutation"] Measurement technique Confirm with laboratory Codes LOINC: 83275-3 ICD-10: E27.40 Clinical summary This test identifies mutations in the SCNN1A gene associated with autosomal recessive pseudohypoaldosteronism type 1 (PHA1). It analyzes the entire gene sequence to detect variants causing salt-wasting.
TEST-3667 SCNN1B Gene Liddle Syndrome Genetic Test This test identifies pathogenic variants in the SCNN1B gene associated with Liddle syndrome, a cause of early-onset severe hypertension.	Whole Blood (Peripheral Venipuncture)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SCNN1B gene", "Single nucleotide variants", "Small insertions/deletions", "Copy Number Variations (CNV)"] Parameters [] Preparation ["No fasting required", "Provide full clinical history", "Provide prior genetic counseling records if available"] Indications ["Diagnosis of Liddle syndrome", "Evaluation of unexplained severe hypertension", "Family screening for Liddle syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 82069-3 ICD-10: I15.8, Z82.49 Clinical summary This test identifies pathogenic variants in the SCNN1B gene associated with Liddle syndrome, a cause of early-onset severe hypertension.
TEST-3760 SCO1 Gene Mutation Analysis (Hepatic Failure & Early‑Onset Neurologic Disorder) Test This test identifies pathogenic variants in the SCO1 gene associated with early-onset hepatic failure and progressive neurologic disorder.	Whole Blood (EDTA) or Dried Blood Spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCO1 gene pathogenic variants", "Single nucleotide variants", "Insertions", "Deletions", "Copy-number changes"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Suspected mitochondrial hepatocerebral syndrome", "Early-onset liver disease with neurologic impairment", "Family history of SCO1-related disorder"] Measurement technique Confirm with laboratory Codes LOINC: 21660-3 ICD-10: E88.89, G31.89 Clinical summary This test identifies pathogenic variants in the SCO1 gene associated with early-onset hepatic failure and progressive neurologic disorder.
TEST-3479 SDCCAG8 Gene Senior‑Loken Syndrome Type 7 Genetic Test This genetic test evaluates the SDCCAG8 gene for pathogenic variants associated with Senior‑Loken syndrome type 7.	Whole blood (EDTA tube), extracted DNA, or FTA card	3–4 weeks (preliminary verbal result available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SDCCAG8 gene"] Parameters [] Preparation ["No fasting required", "Avoid alcohol and tobacco 24 hours prior"] Indications ["Suspected Senior‑Loken syndrome type 7", "Family history of ciliopathies", "Presence of renal, hepatic, and ophthalmologic findings suggestive of the syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: Q87.8, Z13.71, Z84.81 Clinical summary This genetic test evaluates the SDCCAG8 gene for pathogenic variants associated with Senior‑Loken syndrome type 7.
TEST-4351 SDHA Gene Dilated Cardiomyopathy Type 1GG Genetic Test This test evaluates the SDHA gene for pathogenic variants associated with Dilated Cardiomyopathy Type 1GG.	Whole Blood (Peripheral) – Standard Venipuncture or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SDHA gene", "Likely pathogenic variants in the SDHA gene", "Copy Number Variations (CNVs) in the SDHA gene"] Parameters [{"name": "SDHA Gene Analysis", "reference_range": "Negative for pathogenic/likely pathogenic variants"}] Preparation ["No fasting or special diet required", "Mandatory pre-test genetic counselling session required"] Indications ["Definitive diagnosis of Dilated Cardiomyopathy Type 1GG", "Family cascade screening for SDHA variants", "Guiding prophylactic clinical interventions", "Evaluation of patients with unexplained cardiomyopathy"] Measurement technique Confirm with laboratory Codes LOINC: 94800-2 ICD-10: I42.8 Clinical summary This test evaluates the SDHA gene for pathogenic variants associated with Dilated Cardiomyopathy Type 1GG.
TEST-4646 SDHA Gene Leigh Syndrome Genetic Test This test evaluates the SDHA gene for mutations associated with Leigh syndrome, a severe mitochondrial disorder.	Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SDHA gene sequence", "Copy Number Variations (CNVs) in SDHA gene"] Parameters [] Preparation ["No specific fasting required.", "No medication or diet restrictions."] Indications ["Clinical suspicion of Leigh syndrome", "Family history of mitochondrial disorders", "Need for accurate diagnosis to guide therapy", "Family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 95219-5 ICD-10: G31.81 Clinical summary This test evaluates the SDHA gene for mutations associated with Leigh syndrome, a severe mitochondrial disorder.
TEST-2110 SDHD Gene Carcinoid Tumor (Intestinal) Genetic Test This genetic test analyzes the SDHD gene for mutations associated with an increased risk of hereditary intestinal carcinoid tumors and paragangliomas.	Peripheral whole blood, buccal swab, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SDHD gene mutations", "Germline variants"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Individuals with a personal or family history of intestinal carcinoid tumors or paragangliomas", "Screening for hereditary predisposition"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: C7A.0, C7A.1, C7A.2 Clinical summary This genetic test analyzes the SDHD gene for mutations associated with an increased risk of hereditary intestinal carcinoid tumors and paragangliomas.
TEST-1950 SDHD Gene Paraganglioma Type 1 Genetic Test This test evaluates the SDHD gene for germline mutations associated with hereditary paraganglioma type 1 syndrome.	Peripheral Whole Blood	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SDHD gene sequence", "Germline mutations"] Parameters [] Preparation ["Genetic counseling session required", "No fasting or special diet required"] Indications ["Personal or family history of paragangliomas", "Personal or family history of pheochromocytomas", "Early-onset sensorineural deafness", "Known familial SDHD mutation"] Measurement technique Confirm with laboratory Codes LOINC: 94483-2 ICD-10: D44.7 Clinical summary This test evaluates the SDHD gene for germline mutations associated with hereditary paraganglioma type 1 syndrome.
TEST-3498 SECISBP2 Gene Thyroid Hormone Metabolism Abnormalities Genetic Test This genetic test detects pathogenic variants in the SECISBP2 gene associated with thyroid hormone metabolism abnormalities.	Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SECISBP2 gene", "Thyroid hormone metabolism disruption", "Selenoprotein synthesis disruption"] Parameters [] Preparation ["No specific fasting required", "Avoid sample collection during acute illness"] Indications ["Suspected genetic cause of thyroid hormone metabolism abnormalities", "Family history of related disorders", "Guiding targeted therapy", "Family cascade screening"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E07.89 Clinical summary This genetic test detects pathogenic variants in the SECISBP2 gene associated with thyroid hormone metabolism abnormalities.
TEST-3670 SEMA3A Gene (Kallmann Syndrome) Sequencing Test This test evaluates the SEMA3A gene for mutations associated with Kallmann syndrome.	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SEMA3A gene variants", "Pathogenic mutations"] Parameters [] Preparation [] Indications ["Diagnosis of Kallmann syndrome", "Genetic counseling for Kallmann syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: E23.0 Clinical summary This test evaluates the SEMA3A gene for mutations associated with Kallmann syndrome.
TEST-4322 SERPIN1 Gene Familial Encephalopathy with Neuroserpin Inclusion Bodies Genetic Test This genetic test evaluates the SERPIN1 gene for pathogenic variants associated with Familial Encephalopathy with Neuroserpin Inclusion Bodies (FENIB).	Peripheral blood (EDTA), dried blood spot (FTA card), or extracted genomic DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SERPIN1 gene sequence", "Copy Number Variants (CNVs) in SERPIN1"] Parameters [{"name": "Sensitivity", "reference_range": "99.9% for SERPIN1 pathogenic variants"}, {"name": "Coverage Depth", "reference_range": ">500×"}] Preparation ["No specific fasting required.", "Do not discontinue prescribed medications unless advised by your physician."] Indications ["Suspected diagnosis of Familial Encephalopathy with Neuroserpin Inclusion Bodies (FENIB)", "Family history of FENIB", "Carrier screening in at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G31.89, G31.8 Clinical summary This genetic test evaluates the SERPIN1 gene for pathogenic variants associated with Familial Encephalopathy with Neuroserpin Inclusion Bodies (FENIB).

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.